Why are female action stars always in heels?!
11 April 2012
05 April 2012
19 February 2012
A person with an infection of the skull bone behind the ear on the right side, recovered, had a stroke, had a portion of skull removed to accomodate swelling, had the skull replaced and now appears to have developed an infection of the skull bone behind the left ear. Cultured the drainage and tested the susceptibility of the bacteria. Antibiotics recommended, person is recovering.
A person on dialysis with endocarditis and known brain abscesses. We helped identify the organism, choose antibiotics and he is undergoing pre-surgical workup. Kinda grumpy.
A person with multiple antibiotic allergies who has an infection of the inside of the nose. There is always a concern that if inadequately treated, an infection like this will spread backwards to the brain. Broad antibiotics were started until we can grow the bug in culture and narrow them.
The patient with ulcerative colitis who had a blood infection and a clot in their arm... the clot was not surgically removed and they cleared the bacteria from their blood. Was discharged to complete antibiotics at home.
12 February 2012
Every profession has its own language that tends to make it indecipherable to outsiders. I love the medical language; it's succinct and exquisitely precise. But then, I speak doctor, fluently. In my previous post, I left out lots of details because explaining them in everyday English would have made the post three times as long. But for the curious and the fluent out there, here's the untranslated version:
11 February 2012
For my last clinical (in-hospital) month of medical school, I have registered for an infectious diseases consult month. First I will describe what a consult service is, after that we get to the cases I saw during the first week.
01 February 2012
One of the wonderful side effects of having lots more free time during the interview season has been all the reading I've done. Besides the usual suspects (news, entertainment, health) online, I got through a decent pile of really great fiction:
23 January 2012
On Jan 21st I was part of a team of finalists representing Ross
business school in the Kellogg biotech and healthcare case competition. One week prior we had been given a dilemma
surrounding the issue of infant HIV diagnosis in a poor African nation. We had to come up with a pilot program for a new point-of-care testing method and justify our strategy. There were thirty-six entrants, of which 11 finalists were chosen. Each finalist team had 1/2 hour to present their solution.